KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

Position in PBH — Prestige Consumer Healthcare Inc.

CIK 1021223 LOS ANGELES, CA

Back to PBH Full portfolio

Position in PBH

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$130,548,456

-$1,321,320 QoQ

Shares Held

2,202,606

+3.0% QoQ

Ownership

4.65%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2024

6 quarters on record

Voting authority Sole 60.05840354561823.ToString("F0")% Shared 19.714964909747817.ToString("F0")% None 20.226631544633946.ToString("F0")%

Common Shares in PBH Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds $146,457,732 across 6 Drug Manufacturers - Specialty & Generic names. PBH ranks #1 (89.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PBH	Prestige Consumer Healthcare Inc. This page	2,202,606	$130,548,456
2	HLN	Haleon plc	1,583,730	$15,853,137
3	ZTS	Zoetis Inc.	383	$45,274
4	VTRS	Viatris Inc	614	$8,295
5	PRGO	PERRIGO Co plc	129	$1,385
6	UTHR	UNITED THERAPEUTICS Corp	2	$1,185

All Filings in PBH

Export CSV

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$130,548,456	2,202,606	+3.0%	Shares	Defined	2026-05-14
2025-12-31	$131,869,776	2,137,620	-3.4%	Shares	Defined	2026-02-13
2025-09-30	$138,146,672	2,213,889	+26.6%	Shares	Defined	2025-11-13
2025-06-30	$139,653,017	1,748,942	+10.6%	Shares	Defined	2025-08-13
2025-03-31	$135,903,007	1,580,819	+45.3%	Shares	Defined	2025-05-14
2024-12-31	$84,932,245	1,087,620	—	Shares	Defined	2025-02-21
No filing history on record for this holder in this stock.